Secondly, the proportion of bladder and upper tract carcinomas because there is evidence that patients with UTUC have lower PD-L1 expression than those with bladder urothelial carcinoma and they both exhibit significant differences in the prevalence of genomic landscape and carcinogenesis (Yang et al. 2021). This evidence concerns the gene CD274 and bladder transitional cell carcinoma.